Avanos Medical Inc (AVNS)

NYSE
Currency in USD
14.46
-0.01(-0.07%)
Closed
After Hours
14.460.00(0.00%)
AVNS Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
14.4014.65
52 wk Range
14.2525.36
Key Statistics
Edit
Prev. Close
14.47
Open
14.56
Day's Range
14.4-14.65
52 wk Range
14.25-25.36
Volume
333.56K
Average Volume (3m)
518.81K
1-Year Change
-24.25%
Book Value / Share
19.2
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVNS Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
17.00
Upside
+17.57%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Avanos Medical Inc Company Profile

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Avanos Medical Inc SWOT Analysis


Transformation Hurdles
Avanos Medical faces challenges in its three-year plan, with mixed segment performance and leadership changes impacting its strategic direction
Financial Landscape
Despite revenue shortfalls, Avanos maintains profitability and liquidity. Analysts project growth, with price targets reflecting cautious optimism
Segment Dynamics
Explore the contrasting fortunes of Avanos' business units: Digestive Health's robust growth versus Pain Management's persistent volatility
Future Trajectory
Delve into Avanos' ambitious 2025 targets, including margin expansion and free cash flow goals, amidst ongoing transformation efforts
Read full SWOT analysis

Avanos Medical Inc Earnings Call Summary for Q4/2024

  • Q4 2024 EPS of $0.43 beat $0.40 forecast; revenue of $179.6M exceeded $177.23M estimate; shares up 5.56% pre-market
  • Full year 2024 sales reached $688M; free cash flow increased by $70M to $83M; adjusted EBITDA at $29M for Q4
  • 2025 guidance: net sales $665M-$685M, adjusted EPS $1.05-$1.25; targeting long-term gross margins over 60%, EBITDA margins of 20%
  • Completed sale of Respiratory Health business; focus on organic growth in Specialty Nutrition Systems and potential M&A in this segment
  • Risks include currency headwinds, pricing pressures, and potential tariff impacts; company continues restructuring and cost transformation efforts
Last Updated: 2025/02/26, 17:00
Read Full Transcript

Compare AVNS to Peers and Sector

Metrics to compare
AVNS
Peers
Sector
Relationship
P/E Ratio
−1.7x−12.8x−0.5x
PEG Ratio
0.00−0.310.00
Price/Book
0.8x7.9x2.6x
Price / LTM Sales
1.0x3.8x3.0x
Upside (Analyst Target)
17.6%57.6%56.6%
Fair Value Upside
Unlock−13.9%10.1%Unlock

Analyst Ratings

0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 17.00
(+17.57% Upside)

Earnings

Latest Release
Feb 26, 2025
EPS / Forecast
0.43 / 0.40
Revenue / Forecast
179.60M / 177.23M
EPS Revisions
Last 90 days

FAQ

What Is the Avanos Medical (AVNS) Stock Price Today?

The Avanos Medical stock price today is 14.46

What Stock Exchange Does Avanos Medical Trade On?

Avanos Medical is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Avanos Medical?

The stock symbol for Avanos Medical is "AVNS."

What Is the Avanos Medical Market Cap?

As of today, Avanos Medical market cap is 665.21M.

What is Avanos Medical Earnings Per Share?

The Avanos Medical EPS is -8.52.

What Is the Next Avanos Medical Earnings Date?

Avanos Medical will release its next earnings report on 29 Apr 2025.

From a Technical Analysis Perspective, Is AVNS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.